ROTHSCHILD INVESTMENT LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 85338 CHICAGO, IL

Position in TEVA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$84,835

+$10,981 QoQ

Shares Held

2,504

+2.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#525

of 675 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ROTHSCHILD INVESTMENT LLC holds $2,410,092 across 43 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	5,066	$853,823
2	TAK	Takeda Pharmaceutical Co Ltd	19,966	$320,054
3	VTRS	Viatris Inc	17,747	$281,822
4	ZTS	Zoetis Inc.	3,502	$251,653
5	UTHR	UNITED THERAPEUTICS Corp	350	$189,640
6	PRGO	PERRIGO Co plc	17,438	$181,180
7	TEVA	Teva Pharmaceutical Industries Ltd This page	2,504	$84,835
8	AMRX	Amneal Pharmaceuticals, Inc.	4,301	$74,450

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$84,835	2,504	+2.1%	Shares	Sole	2026-08-06
2026-03-31	$73,854	2,452	-4.1%	Shares	Sole	2026-05-07
2025-12-31	$79,772	2,556	-6.6%	Shares	Sole	2026-02-10
2025-09-30	$55,307	2,738	+97.0%	Shares	Sole	2025-11-07
2025-06-30	$23,296	1,390	+6.8%	Shares	Sole	2025-08-11
2025-03-31	$20,011	1,302	-15.2%	Shares	Sole	2025-04-08
2024-12-31	$33,853	1,536	-34.8%	Shares	Sole	2025-02-04
2024-09-30	$42,455	2,356	+550.8%	Shares	Sole	2024-10-18
2024-06-30	$5,882	362	+71.6%	Shares	Sole	2024-07-31
2024-03-31	$2,977	211	+12.8%	Shares	Sole	2024-07-31
2023-12-31	$1,952	187	—	Shares	Sole	2024-07-31
No filing history on record for this holder in this stock.